7648 related articles for article (PubMed ID: 15487985)
1. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts.
Boukouvala S; Sim E
Basic Clin Pharmacol Toxicol; 2005 May; 96(5):343-51. PubMed ID: 15853926
[TBL] [Abstract][Full Text] [Related]
3. Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1).
Butcher NJ; Arulpragasam A; Pope C; Minchin RF
Biochem J; 2003 Dec; 376(Pt 2):441-8. PubMed ID: 12946272
[TBL] [Abstract][Full Text] [Related]
4. Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice.
Boukouvala S; Price N; Plant KE; Sim E
Biochem J; 2003 Nov; 375(Pt 3):593-602. PubMed ID: 12904181
[TBL] [Abstract][Full Text] [Related]
5. Human glucocorticoid receptor alpha transcript splice variants with exon 2 deletions: evidence for tissue- and cell type-specific functions.
Geng CD; Pedersen KB; Nunez BS; Vedeckis WV
Biochemistry; 2005 May; 44(20):7395-405. PubMed ID: 15895983
[TBL] [Abstract][Full Text] [Related]
6. Alternative splice variants of the human PKR protein kinase possessing different 5'-untranslated regions: expression in untreated and interferon-treated cells and translational activity.
Kawakubo K; Kuhen KL; Vessey JW; George CX; Samuel CE
Virology; 1999 Nov; 264(1):106-14. PubMed ID: 10544135
[TBL] [Abstract][Full Text] [Related]
7. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
8. Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1).
Husain A; Barker DF; States JC; Doll MA; Hein DW
Pharmacogenetics; 2004 Jul; 14(7):397-406. PubMed ID: 15226672
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1.
Yuan Z; Tie A; Tarnopolsky M; Bakovic M
Physiol Genomics; 2006 Jun; 26(1):76-90. PubMed ID: 16609143
[TBL] [Abstract][Full Text] [Related]
10. Structure and transcription promoter activity of mouse flap endonuclease 1 gene: alternative splicing and bidirectional promoter.
Emoto M; Miki M; Sarker AH; Nakamura T; Seki Y; Seki S; Ikeda S
Gene; 2005 Aug; 357(1):47-54. PubMed ID: 15967598
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells.
Peng X; Mehta RG; Tonetti DA; Christov K
Oncogene; 2005 Feb; 24(7):1296-301. PubMed ID: 15558014
[TBL] [Abstract][Full Text] [Related]
12. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
Lange C; Walther W; Schwabe H; Stein U
Biochem Biophys Res Commun; 2000 Nov; 278(1):125-33. PubMed ID: 11071864
[TBL] [Abstract][Full Text] [Related]
13. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
[TBL] [Abstract][Full Text] [Related]
14. Variants of the 5'-untranslated region of human NCF2: expression and translational efficiency.
Gauss KA; Bunger PL; Crawford MA; McDermott BE; Swearingen R; Nelson-Overton LK; Siemsen DW; Kobayashi SD; Deleo FR; Quinn MT
Gene; 2006 Jan; 366(1):169-79. PubMed ID: 16310324
[TBL] [Abstract][Full Text] [Related]
15. Alternative promotion of the mouse acyl-CoA synthetase 6 (mAcsl6) gene mediates the expression of multiple transcripts with 5'-end heterogeneity: genetic organization of mAcsl6 variants.
Lee EJ; Kim HC; Cho YY; Byun SJ; Lim JM; Ryoo ZY
Biochem Biophys Res Commun; 2005 Feb; 327(1):84-93. PubMed ID: 15629433
[TBL] [Abstract][Full Text] [Related]
16. A splice variant acquiring an extra transcript leader region decreases the translation of glutamine synthetase gene.
Shin D; Park S; Park C
Biochem J; 2003 Aug; 374(Pt 1):175-84. PubMed ID: 12749766
[TBL] [Abstract][Full Text] [Related]
17. Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia.
Anney RJ; Rees MI; Bryan E; Spurlock G; Williams N; Norton N; Williams H; Cardno A; Zammit S; Jones S; Jones G; Hoogendoorn B; Smith K; Hamshere ML; Coleman S; Guy C; O'Donovan MC; Owen MJ; Buckland PR
Mol Psychiatry; 2002; 7(5):493-502. PubMed ID: 12082567
[TBL] [Abstract][Full Text] [Related]
18. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
[TBL] [Abstract][Full Text] [Related]
20. Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.
Barker DF; Husain A; Neale JR; Martini BD; Zhang X; Doll MA; States JC; Hein DW
Pharmacogenet Genomics; 2006 Jul; 16(7):515-25. PubMed ID: 16788383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
